Key Record Dates
| ClinicalTrials.gov Identifier: | NCT00892177 |
|---|---|
| Brief Title: | Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme |
| First Submitted : | May 1, 2009 |
| First Submitted that Met QC Criteria : | May 1, 2009 |
| First Posted : | May 4, 2009 (Estimate) |
| Results First Submitted : | March 13, 2017 |
| Results First Submitted that Met QC Criteria : | May 23, 2017 |
| Results First Posted : | June 27, 2017 |
| Last Update Submitted that Met QC Criteria : | October 4, 2019 |
| Last Update Posted : | October 21, 2019 |